Enjoy complimentary customisation on priority with our Enterprise License!
The ventricular assist devices market share is expected to increase by USD 4.05 billion from 2020 to 2025, and the market’s growth momentum will accelerate at a CAGR of 21.46%.
The market research report provides valuable insights into the post-COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers market segmentation by product (left and right ventricular assist devices and bi-ventricular assist devices) and geography (North America, Europe, Asia, and ROW).
The ventricular assist devices market report also offers information on several market vendors, including Abbott Laboratories, Abiomed Inc., Asahi Kasei Corp., Berlin Heart GmbH, Calon Cardio-Technology Ltd, CorWave SA, Jarvik Heart Inc., LivaNova Plc, Medtronic Plc, and Mohawk Innovative Technology Inc. among others.
Abiomed Inc. - The company is involved in offering a wide range of products such as the OXY-1 System which is a compact cardiopulmonary support system with an integrated oxygen concentrator. Under the unified segment, the company engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It distributes its products under the Impella brand.
Get the Ventricular Assist Devices Market Size Forecast by Downloading the Report Sample
Technavio categorises the global ventricular assist devices market as a part of the global healthcare equipment market. Our research report extensively covers external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the ventricular assist device market during the forecast period.
Based on our research output, there has been a positive impact on the market growth during and post-COVID-19 era. The increasing prevalence of heart failure is notably driving the ventricular assist devices market growth, although factors such as high costs associated with ventricular assist devices may impede the market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
Key Ventricular Assist Devices Market Driver
Key Ventricular Assist Devices Market Challenge
This ventricular assist devices market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2021-2025.
Our In-house experts produce extensive information on the value chain and parent market of the ventricular assist device market, which vendors can leverage to gain a competitive advantage during the forecast period. The Value Chain information provides an end-to-end understanding of product insight and profit and also optimization and evaluation of business strategies. The players across the value chain include selective data and analysis from entire research findings as per the scope of the report.
Get a glance at the market share of various regions by Requesting a PDF Sample now!
38% of the market’s growth will originate from North America during the forecast period. The US and Canada are the key markets for ventricular assist devices in North America. Market growth in this region will be faster than the growth of the market in the ROW regions.
In 2020, the global ventricular assist devices market in North America was growing, mainly due to the increasing prevalence and incidence of CVDs that lead to heart failure, the growing geriatric population, increasing awareness about heart transplant procedures, the rising adoption of technologically advanced medical devices, growing awareness among healthcare professionals about the benefits of ventricular assist devices over donor organs, and increasing healthcare expenditure. This will facilitate the ventricular assist devices market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.
To gain insights on the market contribution of various segments Request a PDF Sample
The ventricular assist devices market share growth by the left and right ventricular assist devices segment will be significant during the forecast period. The increasing prevalence of end-stage heart failure among people, the growing geriatric population, the increasing demand for left ventricular assist devices, the easy availability of these devices, and the rising number of new product launches are the major factors driving the growth of the left ventricular and right ventricular assist devices segment. Some of the prominent vendors present in the global ventricular assist devices market offer a comprehensive range of left ventricular and right ventricular assist devices for patients suffering from cardiac failure.
This report provides an accurate prediction of the contribution of all the segments to the growth of the ventricular assist device market size and actionable market insights on the post-COVID-19 impact on each segment.
Ventricular Assist Devices Market Scope |
|
Report Coverage |
Details |
Page number |
120 |
Base year |
2020 |
Forecast period |
2021-2025 |
Growth momentum & CAGR |
Accelerate at a CAGR of 21.46% |
Market growth 2021-2025 |
USD 4.05 billion |
Market structure |
Concentrated |
YoY growth (%) |
16.43 |
Regional analysis |
North America, Europe, Asia, and ROW |
Performing market contribution |
North America at 38% |
Key countries |
US, Germany, China, Canada, UK, and India |
Competitive landscape |
Leading companies, Competitive Strategies, Consumer engagement scope |
Key companies profiled |
Abbott Laboratories, Abiomed Inc., Asahi Kasei Corp., Berlin Heart GmbH, Calon Cardio-Technology Ltd, CorWave SA, Jarvik Heart Inc., LivaNova Plc, Medtronic Plc, and Mohawk Innovative Technology Inc. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
Executive Summary
Market Landscape
Market Sizing
Five Forces Analysis
Market Segmentation by Product
Customer landscape
Geographic Landscape
Vendor Landscape
Vendor Analysis
Appendix
Get the report (PDF) sent to your email within minutes.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.